Cresco Labs (CRLBF) Payables (2019 - 2026)

Cresco Labs has reported Payables for 8 years, with the latest figure at $14.2 million in Q1 2026.

• For the quarter ending Q1 2026, Payables changed N/A year-over-year to $14.2 million; the trailing twelve-month figure through Mar 2026 stood at $14.2 million (changed N/A YoY), and the FY2025 full-year result was $27.3 million, changed N/A from the prior year.
• Payables for Q1 2026 stood at $14.2 million, down from $27.3 million in the prior quarter.
• The five-year high for Payables was $62.5 million in Q1 2022, with the low at $14.2 million in Q1 2026.
• Historically, Payables has averaged $36.4 million across 5 years, with a median of $35.3 million in 2023.
• The largest YoY upside for Payables was 492.86% in 2022 against a maximum downside of 3.89% in 2022.
• Cresco Labs' Payables stood at $58.0 million in 2022, then tumbled by 32.11% to $39.4 million in 2023, then grew by 5.09% to $41.4 million in 2024, then slumped by 34.02% to $27.3 million in 2025, then slumped by 48.13% to $14.2 million in 2026.
• The last three Payables figures came in at $14.2 million (Q1 2026), $27.3 million (Q4 2025), and $41.4 million (Q3 2024), per Business Quant data.